Phthalic Acid

Phthalic Acid

SCHEMBL251478

O=C(O)c1ccccc1C(=O)O.Oc1ccccc1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.78
ALOX15 P16050 1/20 0.78
CA12 O43570 2/20 0.64
CA1 P00915 2/20 0.64
CA2 P00918 2/20 0.64
CA4 P22748 2/20 0.64
CA9 Q16790 2/20 0.64
CA14 Q9ULX7 2/20 0.64
KDM4E B2RXH2 1/20 0.64
HMGB1 P09429 1/20 0.64
HPGD P15428 1/20 0.64
CA6 P23280 1/20 0.64
CA7 P43166 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
NAPRT Q6XQN6 1/20 0.64
TDP1 Q9NUW8 2/20 0.61
GLA P06280 1/20 0.61
CA3 P07451 1/20 0.61
AKR1C3 P42330 1/20 0.58
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL1779427 1.00 ALDH1A1 (0.78) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL29523381 1.00 ALDH1A1 (0.78) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL18438875 0.97 ALDH1A1 (0.74) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL27771539 0.97 ALDH1A1 (0.74) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL9724323 0.94 ALDH1A1 (0.78) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL1808 0.88 ALDH1A1 (1.00) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL1686043 0.88 ALDH1A1 (1.00) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL5668586 0.88 ALDH1A1 (1.00) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL146125 0.88 ALDH1A1 (1.00) ALDH1A1ALOX15CA12CA1CA2
Phthalic Acid SCHEMBL10477086 0.88 ALDH1A1 (1.00) ALDH1A1ALOX15CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107417942-A Butyl imidazole analog copolymer material and preparation method 北京秦天科技集团有限公司 2017-12-01 CN claimed
JP-60205365-A None JP disclosed
US-20250367212-A1 PHARMACOTHERAPY FOR OBSESSIVE-COMPULSIVE DISORDER TARGETING DOPAMINE D1 SIGNAL IN STRIATAL STRIOSOMES MATSUMOTO SHINICHI (JP) 2025-12-04 US disclosed
EP-4541372-A1 DRUG THERAPY FOR OBSESSIVE-COMPULSIVE DISORDER TARGETING DOPAMINE D1 SIGNAL IN STRIATAL STRIOSOMES Matsumoto, Shinichi (JP) 2025-04-23 EP disclosed
EP-3325584-B1 MARINE DIESEL CYLINDER LUBRICANT OIL COMPOSITIONS CHEVRON ORONITE TECH BV (NL) 2024-04-03 EP disclosed
EP-4121501-B1 LUBRICATING OIL COMPOSITIONS CHEVRON JAPAN LTD (JP) 2024-01-24 EP disclosed
EP-4303358-A1 THE USE OF BORON COMPOUNDS IN PAPER PULPING, PAPER PRODUCTION AND CAUSTIC RECOVERY Eti Maden Isletmeleri Genel Mudurlugu (TR) 2024-01-10 EP disclosed
WO-2023226834-A1 SEMI-AROMATIC POLYESTER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 珠海金发生物材料有限公司 2023-11-30 WO disclosed
WO-2023226835-A1 POLYESTER, AND PREPARATION METHOD THEREFOR AND USE THEREOF 珠海金发生物材料有限公司 2023-11-30 WO disclosed
EP-3529340-B1 MARINE DIESEL LUBRICANT OIL COMPOSITIONS CHEVRON ORONITE TECH BV (NL) 2023-10-25 EP disclosed
US-20060217494-A1 Basic silane coupling agent organic carboxylate composition, method for producing the same, and epoxy resin composition containing the same NIKKO MATERIALS CO., LTD. 2006-09-28 US disclosed
US-20060199744-A1 Low molecular weight ethylene/alpha-olefin interpolymer as base lubricant oils DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-07 US disclosed
US-20060199896-A1 Viscosity index improver for lubricant compositions DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-07 US disclosed
US-7094845-B2 Basic silane coupling agent organic carboxylate composition, method for producing the same, and epoxy resin composition containing the same NIKKO MATERIALS CO., LTD. (JP) 2006-08-22 US disclosed
EP-1452535-A1 BASIC SILANE COUPLING AGENT-ORGANIC CARBOXYLIC ACID SALT COMPOSITION, PROCESS FOR PREPARING THE SALT COMPOSITION AND EPOXY RESIN COMPOSITIONS CONTAINING THE SAME Nikko Materials Company, Limited (JP) 2004-09-01 EP disclosed
US-20040034136-A1 Basic silane coupling agent-organic carboxylic acid salt composition, process for preparing the salt composition and epoxy resin compositions containing the same JX NIPPON MINING & METALS CORPORATION (JP) 2004-02-19 US disclosed
US-6591634-B1 Method for production of metal oxide glass film at a low temperature MORIZANE TOSHINORI (JP) 2003-07-15 US disclosed
US-6408648-B1 ORGANIC METAL COMPOUND IS SUBJECTED TO HYDROLYZATION IN A REACTION LIQUID CONSISTING OF WATER AND AN ORGANIC SOLVENT, WITH HALOGEN IONS AS A CATALYST IN THE PRESENCE OF BORON IONS FOLLOWED BY DEHYDRATION AND CONDENSATION MORIZANE TOSHINORI (JP) 2002-06-25 US disclosed
JP-S60205365-A MEASURING METHOD OF NEUTRALIZATION DEPTH AND DECIDING METHOD OF RUST OF REINFORCING BAR TODA CONSTR CO LTD 1985-10-16 JP disclosed
US-4308180-A TIRE TREADS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217494-A1 Basic silane coupling agent organic carboxylate composition, method for producing the same, and epoxy resin composition containing the same ELOC, ASIC1, OGDH ALDH1A1 182/4885ALOX15 903/4885CA12 40/4885
US-20060199896-A1 Viscosity index improver for lubricant compositions ELOVL1, POLB, ELOVL3 ALDH1A1 3051/4885ALOX15 9/4885CA12 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.